Your browser doesn't support javascript.
loading
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.
Jayne, David; Rovin, Brad; Mysler, Eduardo; Furie, Richard; Houssiau, Frédéric; Trasieva, Teodora; Knagenhjelm, Jacob; Schwetje, Erik; Tang, Weifeng; Tummala, Raj; Lindholm, Catharina.
Afiliação
  • Jayne D; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Rovin B; Department of Internal Medicine-Nephrology, The Ohio State University, Columbus, Ohio, USA.
  • Mysler E; Rheumatology, Organizacion Medica de Investigacion SA, Buenos Aires, Argentina.
  • Furie R; Division of Rheumatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.
  • Houssiau F; Rheumatology Department, Cliniques universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Universite catholique de Louvain, Brussels, Belgium.
  • Trasieva T; BioPharmaceuticals R&D, AstraZeneca, Goteborg, Sweden.
  • Knagenhjelm J; BioPharmaceuticals R&D, AstraZeneca, Goteborg, Sweden.
  • Schwetje E; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Tang W; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Tummala R; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Lindholm C; BioPharmaceuticals R&D, AstraZeneca, Goteborg, Sweden Catharina.Lindholm@astrazeneca.com.
Lupus Sci Med ; 10(2)2023 08.
Article em En | MEDLINE | ID: mdl-37607780
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article